PMID- 19733629 OWN - NLM STAT- MEDLINE DCOM- 20100114 LR - 20161125 IS - 1872-7972 (Electronic) IS - 0304-3940 (Linking) VI - 465 IP - 1 DP - 2009 Nov 6 TI - Amelioration of cognitive ability in senescence-accelerated mouse prone 8 (SAMP8) by intra-bone marrow-bone marrow transplantation. PG - 36-40 LID - 10.1016/j.neulet.2009.09.001 [doi] AB - Bone marrow cells (BMCs) can increase the number of activated microglias, which play a central role in the inflammatory response in Alzheimer's disease (AD). Senescence-accelerated mouse (SAM) prone 8 (SAMP8) are widely used in various experiments because of cognitive deficits observed with age. In the present study, 4-month-old SAMP8 were reconstituted with BMCs of C57BL/6 mice by intra-bone marrow-bone marrow transplantation (IBM-BMT), which can reconstitute both donor-derived hemopoietic stem cells and mesenchymal stem cells. Three months after IBM-BMT, the impairment of spatial memory in SAMP8 was found to be ameliorated after analyzing the results of the water maze test. Although IL-1beta, IL-6 and iNOS increased and TGF-beta decreased in 7M SAMP8, IL-1beta, IL-6 and iNOS decreased while TGF-beta increased after IBM-BMT by RT-PCR. Moreover, oxidative stress-related heme oxygenase-1 (HO-1) increased in 7M SAMP8, but significantly decreased after IBM-BMT. In conclusion, this is the first report suggesting that the impaired cognitive ability of SAMP8 is ameliorated by IBM-BMT. It seems likely that decreases in IL-1beta, IL-6, iNOS and HO-1 are a result of the development of donor-derived BMCs. FAU - Li, Ming AU - Li M AD - First Department of Pathology, Kansai Medical University, Moriguchi City, Osaka, Japan. FAU - Inaba, Muneo AU - Inaba M FAU - Guo, Kequan AU - Guo K FAU - Abraham, Nader G AU - Abraham NG FAU - Ikehara, Susumu AU - Ikehara S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090905 PL - Ireland TA - Neurosci Lett JT - Neuroscience letters JID - 7600130 RN - 0 (Interleukin-1beta) RN - 0 (Interleukin-6) RN - 0 (Transforming Growth Factor beta) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.14.13.39 (Nos2 protein, mouse) RN - EC 1.14.14.18 (Heme Oxygenase-1) SB - IM MH - *Aging MH - Animals MH - Bone Marrow Transplantation/*methods MH - Brain/*metabolism MH - Cognition Disorders/*metabolism/*surgery MH - Heme Oxygenase-1/metabolism MH - Interleukin-1beta/metabolism MH - Interleukin-6/metabolism MH - Leukocytes, Mononuclear/metabolism MH - Male MH - Maze Learning MH - Memory Disorders/metabolism/surgery MH - Mice MH - Mice, Inbred C57BL MH - Mice, Mutant Strains MH - Nitric Oxide Synthase Type II/metabolism MH - Transforming Growth Factor beta/metabolism EDAT- 2009/09/08 06:00 MHDA- 2010/01/15 06:00 CRDT- 2009/09/08 06:00 PHST- 2009/05/25 00:00 [received] PHST- 2009/08/24 00:00 [revised] PHST- 2009/09/01 00:00 [accepted] PHST- 2009/09/08 06:00 [entrez] PHST- 2009/09/08 06:00 [pubmed] PHST- 2010/01/15 06:00 [medline] AID - S0304-3940(09)01199-9 [pii] AID - 10.1016/j.neulet.2009.09.001 [doi] PST - ppublish SO - Neurosci Lett. 2009 Nov 6;465(1):36-40. doi: 10.1016/j.neulet.2009.09.001. Epub 2009 Sep 5.